Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (1000)	3/30/1999 3:38:00 PM
From: N	Read Replies (2) \| Respond to of 1972

Scott, could you please comment on this article in the 3/27/99 Economist, if you are so inclined: "...According to Glenn Crocker, a consultant with Ernst and Young and author of a recent report on American biotechnology, ...almost half of the country's 327 public biotech firms have less than two years worth of cash left in their coffers.... ...The serious institutional money, which tends to stay put a little longer, is no longer directed towards small cap biotechnology (later article says switched to internet stocks) firms...." Thanks, Nancy